Your session is about to expire
← Back to Search
Alpha-1 Adrenergic Receptor Antagonist
Tamsulosin for Kidney Stones
N/A
Waitlist Available
Led By Swor Robert, DO
Research Sponsored by Robert Swor
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-7 days
Awards & highlights
All Individual Drugs Already Approved
Approved for 5 Other Conditions
Summary
To determine if emergency department patients with acute ureteral colic pain due to a ureteral stone who are treated with tamsulosin, versus placebo, will experience a shorter time to passage of their stone or resolution of their pain. A secondary study objective will be to determine if there is a relationship between response to tamsulosin and stone size or position in the ureter.
Eligible Conditions
- Kidney stones
- Kidney Stones
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-7 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-7 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Stone Passage
Secondary study objectives
High Pain Score by Treatment Group
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 5 Other Conditions
This treatment demonstrated efficacy for 5 other conditions.
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: TamsulosinActive Control1 Intervention
Intervention - Tamsulosin
Group II: PlaceboPlacebo Group1 Intervention
Placebo
Find a Location
Who is running the clinical trial?
Robert SworLead Sponsor
William Beaumont HospitalsOTHER
151 Previous Clinical Trials
112,483 Total Patients Enrolled
Swor Robert, DOPrincipal InvestigatorWilliam Beaumont Hospitals
Share this study with friends
Copy Link
Messenger